And in our research, we found that NF-κB protein level was significantly increased in the T2DM-NASH group, and nuclear translocation of p65 was reduced by celecoxib in the T2DM-NASH-Cele group. Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.